European Archives - Page 882 of 1102 - European Medical Journal

Continue
9 Mins
8 Aug 2017

Shifting Treatment Paradigms in Non-Hodgkin Lymphomas

Despite significant therapeutic advances in the treatment of patients with non-Hodgkin lymphoma (NHL), a significant proportion experience relapse or…
2 Mins
8 Aug 2017

Haemoglobin Level and White Cell Count in Patients Clinically Suspected to have Essential Thrombocythaemia may help in Predicting Early Primary Myelofibrosis or Unclassifiable Myeloproliferative Neoplasm

Accurate diagnosis of essential thrombocythaemia (ET) and differentiation between ET and pre-fibrotic stages of primary myelofibrosis (PMF) can be…
9 Mins
8 Aug 2017

Biosimilars for Haematologic Malignancies: The Path to Sustainable Care

The main objectives of this symposium were to review the value of biosimilars in sustainable treatment for haematologic malignancies and to recognise the…
1 Mins
8 Aug 2017

Front-Line Vascular Access Devices in Peripherally Inserted Acute Leukaemias: Central Catheter Versus Traditional Central Venous Catheter: A Phase IV Randomised Trial

For high-risk haematological patients, in particular those with acute leukaemia, there is limited information on the use of peripherally inserted…
9 Mins
8 Aug 2017

Patients in Focus: What’s Relevant for Chronic Myeloid Leukaemia and Philadelphia Chromosome-Positive Acute Lymphoblastic Leukaemia?

This symposium was dedicated to discussing BCR-ABL-positive chronic myeloid leukaemia (CML) and Philadelphia-positive acute lymphoblastic leukaemia (Ph+ALL)
8 Mins
8 Aug 2017

Editor’s Pick: The Role and Regulation of Quiescence in Acute Lymphoblastic Leukaemia

There are ˜3,000 children, as well an additional ˜7,000 adults, diagnosed with acute lymphoblastic leukaemia (ALL) each year in the USA.
1 Mins
8 Aug 2017

Oral Rigosertib Combined With Azacitidine in Patients with Myelodysplastic Syndromes and Acute Myeloid Leukaemia: Effects in Treatment Naïve and Relapsed/ Refractory Patients

Azacitidine is the standard of care for higher risk myelodysplastic syndromes (MDS); however, only approximately 50% of patients respond, and those…
7 Mins
8 Aug 2017

Thrombocytopenia: A Defect in Actin Dynamics?

The actin cytoskeleton plays many important roles in the lifecycle of platelets, from biogenesis from megakaryocytes, to activation and clearance from…
2 Mins
8 Aug 2017

Minimal Residual Disease Monitoring by Digital PCR for JAK2V617F Detection in Patients with Myelofibrosis or Acute Myeloid Leukaemia Secondary to Myelofibrosis after Allogeneic Stem Cell Transplantation

Myelofibrosis (MF) is one of the BCR-ABL1-negative chronic myeloproliferative neoplasms (MPNs), characterised by clonal expansion of abnormal…
8 Mins
8 Aug 2017

The Role of Allograft in Acute Lymphoblastic Leukaemia, Including Alternate Donors

The management of acute lymphoblastic leukaemia (ALL) remains challenging.
We’ve noticed you’re accessing
from North/South America.